Cargando…

Lp-PLA(2) Selective Inhibitor (Darapladib) Effect In Lowering The Expression Level Of IL-1B And IL-6 In The Renal At Type 2 Diabetes Mellitus

PURPOSE: The aim of this study is to prove that type 2 diabetes mellitus can induce increasing inflammation marker in renal and that the provision of darapladib as Lp-LA2 Inhibitor agents can inhibit inflammation that were measured from the expression of IL-1B and IL-6- type cytokine in renal. This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wihastuti, Titin Andri, Aini, Fitria Nugraha, Tjahjono, Cholid Tri, Sulfia, Yuni Hendrati, Sholichah, Zuhrotus, Heriansyah, Teuku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830380/ https://www.ncbi.nlm.nih.gov/pubmed/31802883 http://dx.doi.org/10.2147/VHRM.S217904

Ejemplares similares

Dietary Ethanolic Extract of Mangosteen pericarp Reduces VCAM-1, Perivascular Adipose Tissue and Aortic Intimal Medial Thickness in Hypercholesterolemic Rat Model
por: Wihastuti, Titin Andri, et al.
Publicado: (2019)

Polysaccharide peptide (PsP) Ganoderma lucidum: a potential inducer for vascular repair in type 2 diabetes mellitus model
por: Heriansyah, Teuku, et al.
Publicado: (2019)

Expression of Hypoxia-Inducible Factor-1α (HIF1A) and Lp-PLA2 in Low, Intermediate, and High Cardiovascular Disease Risk Population
por: Heriansyah, Teuku, et al.
Publicado: (2020)

The inhibitory effects of polysaccharide peptides (PsP) of Ganoderma lucidum against atherosclerosis in rats with dyslipidemia
por: Wihastuti, Titin Andri, et al.
Publicado: (2017)

Exploration of Adhesion Molecule Expression in Cardiac Muscle of Early Atherosclerosis Dyslipidemic Sprague Dawley Rats
por: Wihastuti, Titin A., et al.
Publicado: (2018)

Differences in senescence of late Endothelial Progenitor Cells in non-smokers and smokers
por: Kumboyono, Kumboyono, et al.
Publicado: (2021)

The reduction of aorta histopathological images through inhibition of reactive oxygen species formation in hypercholesterolemia rattus norvegicus treated with polysaccharide peptide of Ganoderma lucidum
por: Andri Wihastuti, Titin, et al.
Publicado: (2015)

Ascorbic Acid vs Calcitriol in Influencing Monocyte Chemoattractant Protein-1, Nitric Oxide, Superoxide Dismutase, as Markers of Endothelial Dysfunction: In Vivo Study in Atherosclerosis Rat Model
por: Heriansyah, Teuku, et al.
Publicado: (2023)

Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy
por: Morigny, Pauline, et al.
Publicado: (2021)

Effectiveness of diabetes self-management education (DSME) in type 2 diabetes mellitus (T2DM) patients: Systematic literature review
por: Ernawati, Ucik, et al.
Publicado: (2021)

Lp-PLA2 Inhibition—The Atherosclerosis Panacea?
por: Karakas, Mahir, et al.
Publicado: (2010)

Lp-PLA(2) Inhibitors for the Reduction of Cardiovascular Events
por: Steen, Dylan L., et al.
Publicado: (2013)

Lp-PLA2 levels in HIV-infected patients
por: Díaz-Pollán, Beatriz, et al.
Publicado: (2014)

Genetic invalidation of Lp-PLA(2) as a therapeutic target: Large-scale study of five functional Lp-PLA(2)-lowering alleles
por: Gregson, John M, et al.
Publicado: (2016)

Early Detection of Negative Smoking Impacts: Vascular Adaptation Deviation Based on Quantification of Circulated Endothelial Activation Markers
por: Kumboyono, Kumboyono, et al.
Publicado: (2021)

Vasa vasorum anti-angiogenesis through H(2)O(2), HIF-1α, NF-κB, and iNOS inhibition by mangosteen pericarp ethanolic extract (Garcinia mangostana Linn) in hypercholesterol-diet-given Rattus norvegicus Wistar strain
por: Wihastuti, Titin Andri, et al.
Publicado: (2014)

Association Lp-PLA2 Gene Polymorphisms with Coronary Heart Disease
por: Ma, Sha, et al.
Publicado: (2022)

Effect of Colchicine in reducing MMP-9, NOX2, and TGF- β1 after myocardial infarction
por: Suryono, Suryono, et al.
Publicado: (2023)

The Relationship between Intracarotid Plaque Neovascularization and Lp (a) and Lp-PLA2 in Elderly Patients with Carotid Plaque Stenosis
por: Sun, Chang, et al.
Publicado: (2022)

Effects and potential mechanism of atorvastatin treatment on Lp-PLA2 in rats with dyslipidemia
por: Zheng, Dongdan, et al.
Publicado: (2017)

Lp-PLA(2), a new biomarker of vascular disorders in metabolic diseases
por: De Stefano, Alessandro, et al.
Publicado: (2019)

Association between Lp-PLA2 and coronary heart disease in Chinese patients
por: Yang, Li, et al.
Publicado: (2017)

The changes of Lp-PLA2 in patients with gestational diabetes and its clinical significance
por: Wang, Guo-Hua, et al.
Publicado: (2021)

Homocysteine and Lp-PLA2 levels: Diagnostic value in coronary heart disease
por: Wu, Linlin, et al.
Publicado: (2023)

The Potential Predictive Role of Tumour Necrosis Factor-α, Interleukin-1β, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival
por: Kumboyono, Kumboyono, et al.
Publicado: (2022)

Differential expression of Lp-PLA2 in obesity and type 2 diabetes and the influence of lipids
por: Jackisch, Laura, et al.
Publicado: (2018)

Phospholipase A(2) is an Inflammatory Predictor in Cardiovascular Diseases: Is there any Spacious Room to Prove the Causation?
por: Santoso, Anwar, et al.
Publicado: (2020)

Prehypertension-Associated Elevation in Circulating Lysophosphatidlycholines, Lp-PLA(2) Activity, and Oxidative Stress
por: Kim, Minjoo, et al.
Publicado: (2014)

Identification of Inflammation-Related Biomarker Lp-PLA2 for Patients With COPD by Comprehensive Analysis
por: Deng, Mingming, et al.
Publicado: (2021)

Sequencing of Lp-PLA2-encoding PLA2G7 gene in 2000 Europeans reveals several rare loss-of-function mutations
por: Song, K, et al.
Publicado: (2012)

Genome-Wide Association Study of Lp-PLA(2) Activity and Mass in the Framingham Heart Study
por: Suchindran, Sunil, et al.
Publicado: (2010)

Association of Lp-PLA(2) Mass and Aysmptomatic Intracranial and Extracranial Arterial Stenosis in Hypertension Patients
por: Wang, Yan, et al.
Publicado: (2015)

Lp-PLA(2) activity and mass and CRP are associated with incident symptomatic peripheral arterial disease
por: Fatemi, Shahab, et al.
Publicado: (2019)

On the present and future role of Lp-PLA(2) in atherosclerosis-related cardiovascular risk prediction and management
por: Fras, Zlatko, et al.
Publicado: (2020)

Detection of Vascular Inflammation and Oxidative Stress by Cotinine in Smokers: Measured Through Interleukin-6 and Superoxide Dismutase
por: Kumboyono, Kumboyono, et al.
Publicado: (2022)

Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis
por: Zhang, Juan, et al.
Publicado: (2016)

Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A(2 )(Lp-PLA(2 )): a review
por: Silva, Isis T, et al.
Publicado: (2011)

Lp-PLA2 as a biomarker and its possible associations with SARS-CoV-2 infection
por: Dua, Pamila, et al.
Publicado: (2022)

Baseline elevated Lp-PLA2 is associated with increased risk for re-stenosis after stent placement
por: Zheng, Dongdan, et al.
Publicado: (2014)

Lp‐PLA(2), Plaque Inflammation and Lesion Development Vary Fundamentally Between Different Vascular Sites
por: Marsche, Gunther
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oo9vktn5oifvbd8oeeqnq6k5i4